Tan, Jia Ping
Liu, Yifang
Fu, Yuting
Liang, Langchao
Wu, Yan
Guo, Tiantian
Jia, Shikai
Jiang, Yujia https://orcid.org/0009-0008-4666-0211
Yuan, Tingli
Li, Jie https://orcid.org/0000-0002-5446-894X
Li, Yixin
Huang, Zhi
Li, Shenglong
Li, Jie https://orcid.org/0000-0003-1754-2378
Yan, Xixi
Liao, Zizhuo
Liu, Xiaojing
Hu, Bowen
Fu, Shujie
Hao, Shijie https://orcid.org/0000-0001-9845-3101
Tian, Luyi https://orcid.org/0000-0003-3420-3685
Liu, Zhen https://orcid.org/0000-0002-8619-8307
Yu, Leqian https://orcid.org/0000-0003-2060-463X
Liu, Longqi https://orcid.org/0000-0002-5828-5542
Liu, Xiaodong https://orcid.org/0000-0002-9315-3406
Article History
Received: 22 June 2025
Accepted: 13 April 2026
First Online: 7 May 2026
Competing interests
: X.L. is a co-founder of iCamuno Biotherapeutics Ltd. The remaining authors declare no competing interests.